Solexa named Richard Lussier to the newly created position of vice president of sales and field operations, the company said last week.
He was president and general manager of Applied Biosystems Japan for five years and held other managerial positions in US, Japanese, and other Asian field organizations for ABI. He also managed the Asia-Pacific operations for Celera Genomics and held global field operations management positions with MJ Research, now part of Bio-Rad Laboratories, and with Fluidigm.
Lussier received his MBA from Temple University and conducted postgraduate studies in molecular biology at the University of Vermont. He received a BS in biology and chemistry from Rhode Island College.
Clinical Data said last week that it had appointed Robert Bondaryk as general manager and head of its Cogenics unit, the company said. He will report to Drew Fromkin, the company’s CEO. Bondaryk will serve as a member of the senior management team on Cogenics strategy, client development, refinement and enhancement, and will focus on guiding the unit toward profitability, the company added. Bondaryk served most recently as executive vice president and general manager of business development at Proteome Systems. Prior to that position, he served as vice president of life science and drug discovery at Fischer Scientific. Bondaryk earned a PhD in biochemistry from Harvard University, as well as an AB in biology from Bowdoin College.
Clinical Data also appointed Abdul Ally as the Cogenics unit’s vice president of laboratory operations. Ally will manage day-to-day laboratory operations, and will report to Bondaryk, the company said. Ally previously served as director of operations and development at Sigma Proligo and Sigma Genosys. Prior to that position, he served as director of engineering at Marligen Biosciences, and before that as director of R&D in engineering and senior staff scientist of the genome analysis group at Life Technologies. Ally earned an MS in molecular biology from Howard University.